DGAP-News: Eckert & Ziegler: Sales growth in first half of

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Aug 5, 2014 at 2:00 AM

DGAP-News: Eckert & Ziegler: Sales growth in first half of year, no growth in earnings so far

DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Half Year Results Eckert & Ziegler: Sales growth in first half of year, no growth in earnings so far 05.08.2014 / 07:45 --------------------------------------------------------------------- Berlin, August 5, 2014. Berlin-based Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a specialist in isotope technology applications for medicine, science and industry, has increased sales by 8 % year on year to EUR 31.2 million in the second quarter of 2014. Sales rose by EUR 6.6 million, or 12 %, to EUR 61.9 million during the first half year of 2014. A total EUR 2.1 million of this amount was attributable to organic sales growth. Companies that have been acquired since the middle of 2013 contributed EUR 5.7 million in sales. The fall in the US dollar exchange rate, however, had a negative impact of EUR 1.1 million. Earnings before interest and taxes (EBIT) came to EUR 6.2 million in the first half year of 2014, equating to a drop of EUR 0.7 million, or 10 %, year on year. This decrease was primarily the result of negative effects in the Radiation Therapy and Isotope Products segments. At the beginning of 2014, the Radiation Therapy segment recorded integration expenses for the new acquisitions in the US. In addition, sales of tumor radiation equipment suffered on account of the war-like situations in parts of Ukraine and the Middle East. Extraordinary income from the repayment of a loan in the prior year also negatively impacted the segment result when looked at in comparison. The Isotope Products segment had also benefitted from extraordinary income in the prior year due to a successful lawsuit. The Radiopharma segment posted better figures than in the prior year due to the acquisition of an Austrian company as well as an increase in sales in the equipment division. The new Others segment, comprising Environmental Services and Holding, which were previously reported separately, narrowed the EBIT losses from EUR -3.1 million to EUR -1.4 million, which was mainly due to the absence of extraordinary expenses from the same period in 2013 when a price increase in an important disposal channel negatively impacted earnings. Earnings after taxes and minority interests fell by 18 % to EUR 3.3 million, or EUR 0.62 per share due to the decline in EBIT. Cash and cash equivalents fell by EUR 10.6 million to EUR 18.8 million in the first half of 2014. This was caused by increased equity requirements for net working capital as well as higher loan repayments. The latter led to a rise in the equity ratio rose from 51 % to 52 %. The Executive Board has reaffirmed its most recent forecast for the year 2014. Based on expectations of a disproportionate increase in profit in the Radiation Therapy segment, the targets for the year remain at sales of EUR 134 million and earnings after tax and minority interests of EUR 10.5 million, or EUR 2.00 per share. Change in the Supervisory Board: Effective August 1, 2014, the lawyer Prof. Dr. Helmut Grothe took over as the successor of Dr. Fritz Oesterle, who resigned from the Supervisory Board effective July 31 due to other obligations that would not leave him enough time to look after the interests of the company in the future with the required amount of diligence. The Executive Board would like to thank Dr. Oesterle for his hard work and valuable contributions. Prof. Dr. Grothe was elected to become the new member at the last Annual General Meeting in May. To read the full quarterly report, please click here: http://www.ezag.com/fileadmin/ezag/user-uploa...ports/engl isch/euz214e.pdf About Eckert & Ziegler Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), with approximately 700 employees, is one of the world's largest providers of isotope technology for radiation therapy and nuclear medicine. Contributing to saving lives Your contact: Eckert & Ziegler AG, Karolin Riehle, Investor Relations, Robert-RÃ¶ssle-Str. 10, 13125 Berlin Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.com --------------------------------------------------------------------- 05.08.2014 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: Eckert & Ziegler Strahlen- und Medizintechnik AG Robert-RÃ¶ssle-Str.10 13125 Berlin Germany Phone: 49 30 941084-138 Fax: 49 30 941084-112 E-mail: karolin.riehle@ezag.de Internet: www.ezag.de ISIN: DE0005659700 WKN: 565970 Listed: Regulierter Markt in Frankfurt (Prime Standard), Stuttgart; Freiverkehr in Berlin, DÃ¼sseldorf, Hamburg, MÃ¼nchen End of News DGAP News-Service --------------------------------------------------------------------- 280579 05.08.2014

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Infosys Award Recognizes Global Banking Innovation 2026

Championing Banking Innovations Globally If there's one thing you can count on in the financial world, it's innovation pushing the boundaries of how we bank. The 13th edition of the Qorus-Infosys Finacle Banking Innovation Awards has once again proven that innovation is not just a buzzword but a real, transformative force in the global banking landscape. This year, they...

Custom Homes Shine: Florida’s Lucrative Property Move

Why Custom Homes Are Worth the Investment in Florida Ever thought about sinking some cash into Florida's real estate game? Well, building a custom home might just be your golden ticket, according to Paul H Schaefer II from Sage Homes LLC. I mean, everyone knows Florida's housing market is as spicy as a chili pepper, but custom homes seem to be the secret sauce here....

Banco Macro S.A. Plans $160B Share Buyback Initiative

Tapping into Share Buybacks in a Tumultuous Market Out of nowhere, Banco Macro S.A. has decided to whip up a share buyback program, a lifeline for their current market value. Let me tell you, the market's more volatile than a caffeinated squirrel these days, hitting the financial scenery harder than a hammer on a glass table. So, Banco Macro's taken a deep breath and...

5GAA Brings Cutting-Edge Tech to India’s Roads

India's Mobility Challenge: A Crossroads for Innovation When it comes to road networks, India isn't playing with a small deck—the nation’s highways and byways stretch across vast and complicated landscapes. It's like a massive puzzle we're trying to solve. The bigwigs from the 5G Automotive Association (5GAA) just wrapped up their gig in New Delhi, showing off tech...

Solink Secures $100M: NYSE Sees Tech and Sports Moves

Folks, it’s a busy day on Wall Street, with Solink leading the charge by landing over a cool $100 million in fresh funding. Let's break this down because when startups pocket nine-digit figures, it's time to pay attention. Solink's Leap Forward Now, what’s Solink doing with all that cash? They're not scrambling for coffee money, that's for sure. Instead, this funding...

Bitcoin Mortgages: APX Ushers in New Canadian Era

Bitcoin Meets Canadian Mortgages: A Game Changer? Here's a scenario you didn't see coming: Bitcoin, the digital darling of the new millennium, now backing Canadian mortgages. If that doesn't get your financial senses tingling, maybe you haven't been paying attention. APX Lending, a pioneer in digital-asset-backed lending, is kicking open the doors to a fresh financial...

BellRing Brands Lawsuit Hinges on Sales Misrepresentation

BellRing's Legal Tangle Deepens When it comes to drawing the line between having a good quarter and pulling the wool over investors' eyes, the latest lawsuit knotted up with BellRing Brands, Inc. (NYSE: BRBR) shows just how fine that line can be. This legal drama, filed on the not-so-distant date of January 22, 2026, isn't your garden-variety beef. We're talking...

Fan Creations Shine: McLaren's Unique Livery Unveiled

From Sticker Dreams to Racing Reality Some days bring surprises outside the typical ticker watch as those market charts get shoved aside, right when fans' stories race onto the scene. What McLaren and Velo cooked up for the Mexico City Grand Prix has got me pausing—a blend of motorsport passion and grassroots creativity. By unveiling the 'Livery of Dreams,' McLaren puts...

J.H. Strain & Sons' Asset Sale Seals a New Era

Texan Legacy Bows Out of the Asphalt Game Here's a fresh chapter in the world of road construction that'll have folks in the industry doing a double-take. Elder Bray & Bankler, a bigwig among corporate law circles, has been guiding this tale. They've shepherded J.H. Strain & Sons through selling off its asphalt manufacturing and construction assets to none other than...

TIOmarkets App Unveils Enhanced Trading Features

Trading on the Go Takes a Leap Forward Pretty slick development from TIOmarkets, if I do say so myself. They've rolled out a major expansion of their mobile trading app, now packing some hefty features like Depth of Market and more granular order controls right from those little devices in our pockets. Quite the leap if you're one of those folks who can't keep your eyes...